1. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling;Alizadeh;Nature,2000
2. Chronic myeloproliferative diseases with t(5;12) and a PDGFRB fusion gene: complete cytogenetic remissions on STI571;Apperley;Blood,2001
3. Roots of clinical resistance to STI-571 cancer therapy;Barthe;Science,2001
4. Evaluation of the safety and efficacy of an oral molecularly-targeted therapy, STI571, in patients with unresectable or metastatic gastrointestinal stromal tumors (GISTS) expressing c-KIT (CD117);Blanke;Proc. Am. Soc. Clin. Oncol.,2001
5. Point mutations clustered within the ATP binding region of Bcr-Abl are common in patients with emerging Glivec resistance but not in Glivec non-responsive cases;Branford;Blood,2001